Brief: Painchek Says Meeting With FDA Agreeing A Revised Timeline For US De Novo Regulatory Clearance
05/06/2025 02:02
June 5 (Reuters) - PainChek Ltd PCK.AX: MEETING WITH FDA AGREEING A REVISED TIMELINE FOR US DE NOVO REGULATORY CLEARANCE DECISION Further company coverage: PCK.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on PainChek
See all newsPainChek hits over four-month high on expanded Sabra agreement uptake
Brief: PainChek Expands Sabra Contracts To 23 US Communities With 808 Memory Care Licences
Brief: PainChek Says Karen Holzberger Appointed CEO
Brief: Painchek Secures Initial Sabra Us Care Facilities
Brief: Painchek Says Lil Bianchi Appointed Non-Executive Chair